The Late Stage Chronic Kidney Disease (CKD) Drugs Market is experiencing rapid growth as the global incidence of chronic kidney disease continues to rise. According to The Insight Partners, the market was valued at approximately US$ 5.74 billion in 2021 and is projected to expand significantly to US$ 17.95 billion by 2031, registering a strong compound annual...